We have developed a n enzyme mechanism language for the mathematical modeling of biochemical pathways. This language, kMech, is a comprehensive collection of single and multiple substrate enzyme reactions and regulatory mechanisms that extends Cellerator function for the mathematical modeling of enzyme reactions. Each mechanism has been codified to generate a set of elementary reactions t ha t can be translated by Cellerator into ordinary differential equations (ODEs) solvable by Mathematica. We also present methods that use common kinetic measurements to estimate physical constants required to solve these ODEs. Because kMech assembles fundamental modular association-dissociation reaction mechanisms to describe complex enzyme mechanisms, the kMech/Cellerator dynamic modeling system is more flexible, and easily extended, than commonly used simulation systems based on MichaelisMenton kinetic equations. We use this system to model branched chain amino acid biosynthesis in Escherichia coli. Simulations of metabolic perturbations and genetic mutations predict results reported in the literature.
INTRODUCTION
Systems biology may be broadly defined as the integration of diverse data into useful biological models that allow scientists to easily observe complex cellular behaviors and to predict the outcomes of metabolic and genetic perturbations. Current and emerging high-throughput genomic and proteomic technologies now allow us to study the simultaneous behavior of thousands of cellular components in response to such perturbations. In order to integrate the large amounts of data these high-throughput technologies produce, we must develop comp utational methods to simulate complex biological systems.
As a first step towards the elucidation of the systems biology of the model organism, Escherichia coli, we have elected to use a dynamic modeling approach to describe fundamental molecular interactions with differential equations. We have also elected to confine our initial efforts to the complex but well-studied metabolic pathways for the biosynthesis of the branched chain amino acids (L-isoleucine, L-valine, and Lleucine) 1 . However, before we can mathematically simulate carbon flow through these pathways, we must have knowledge of the enzyme mechanism of each step in the pathway, we must know the values of kinetic and physical parameters that describe these mechanisms, and we must be aware of the metabolic regulatory circuits that control these pathways. In the case of E. coli, an organism that has been studied for over fifty years, much of this information is available in the literature.
In this report we present a Cellerator 2 language extension, kMech, that describes a suite of enzyme mechanisms suitable for the mathematical modeling of metabolic pathways * . Each mechanism has been codified to generate a set of elementary reactions that can be translated by Cellerator into ordinary differential equations (ODEs ) solvable by Mathematica. Alternatively, Cellerator can generate ODEs in System Biology Markup Language (SBML) for other simulators 3 . We also present methods that use common kinetic measurements to estimate rate constants required to solve these differential equations. Because kMech assembles fundamental association-dissociation reaction mechanisms to describe complex enzyme mechanisms, the kMech/Cellerator dynamic * A Mathematica TM executable, kMech.m, file and a Mathamatica TM notebook file for the simulation of branched chain amino acid biosynthesis, may be downloaded from the University of California , Irvine, Institute for Genomics and Bioinformatics website at www.igb.uci.edu/tools.htm. modeling system is more flexible, and more easily extended, than commonly used simulation systems based on Michaelis-Menton kinetic equations [4] [5] [6] [7] . Our model incorporates all of the forward and reverse enzyme reactions and regulatory circuits of the branched chain amino acid biosynthesis pathways including: single and multiple substrate (Ping Pong and Bi Bi) enzyme kinetic reactions; feedback inhibition (allosteric, competitive, and non-competitive) mechanisms; channeling of metabolic flow through isozymes and transamination reactions; and active transport mechanisms.
L-threonine deaminase, the first enzyme specific for the biosynthesis of Lisoleucine, is end-product inhibited by L-isoleucine, and α-isopropylmalate synthase, the first enzyme specific for the biosynthesis of L -leucine, is end-product inhibited by Lleucine ( Fig. 1 ). However, because the parallel pathways for L-valine and L-isoleucine biosynthesis are catalyzed by a set of bi-functional enzymes, L-valine inhibition of the first enzyme specific for its biosynthesis might compromise the cell for L -isoleucine biosynthesis. This type of a regulatory problem is often solved by using multiple isozymes that are differentially regulated by multiple end-products. In this case, there are three α-acetohydroxy acid synthase (AHAS) isozymes that catalyze the first step of the L-valine pathway, which is also the second step of the L-isoleucine pathway. AHAS I has a substrate preference for the condensation of two pyruvate molecules required for Lvaline, and is end-product inhibited by L -valine. AHAS II, which has a substrate preference for the condensation of pyruvate and α-ketobutyrate required for L-isoleucine biosynthesis, is not inhibited by any of the branched chain amino acids. The third isozyme, AHAS III shows no preference for pyruvate or α-ketobutyrate but is inhibited by L-valine.
L-threonine deaminase (TDA) is an allosteric enzyme that exists in an active (R)
state and an inactive (T) state. The fraction of active enzyme in the R state is determined by the concentrations and relative affinities of substrate (L-threonine), inhibitor (Lisoleucine), and activator (L-valine) for the R and T states. The kinetic behavior of this enzyme is accurately captured by the Monod, Wyman, Changeux (MWC) concerted allosteric transition model 8 described in the Methods section.
In addition to these regulatory circuits, the intracellular levels of the branched chain amino acids are influenced by the reversible transamination reactions of each pathway. When the intracellular levels of any of these end-product amino acids become high, reverse reactions to their cognate ketoacids are favored. For example, high concentrations of L-valine can be converted to α-ketoisovalarate to supplement L-leucine production. The intracellular amino acid levels can be affected by the active transport of these amino acids from the extracellular growth medium. Therefore, enzymes required for the active transport of the branched chain amino acids into the cell against a concentration gradient are included in our simulations.
RESULTS

Computational Modeling of the Dynamics of Carbon Flow through the Branched
Chain Amino Acid Biosynthesis Pathways of E. coli K12
The three interacting metabolic pathways simulated here consist of eleven enzymes, eighteen metabolic intermediates, and three enzyme cofactors. The mathematical model for this metabolic system consists of 105 ordinary differential equations (ODEs), with 110 association and dissociation rate constants, and 52 catalytic rate constants. The enzymes of these interacting pathways employ three distinct enzyme mechanisms (simple, Bi Bi, and Ping Pong Bi Bi) that are regulated by allosteric, competitive, or noncomptetitive inhibition mechanisms. As described in the Methods section, the physical parameters for these models have been obtained directly from the literature, calculated from data in the literature, or estimated by fitting experimental data.
Relative intracellular enzyme levels ha ve been inferred from DNA microarray data 9 . The time dependent approach to steady state for the thirteen pathway intermediates and endproducts are shown in Figure 2 . Steady-state enzyme activity levels have been optimized to properly channel the metabolic flow of intermediates through these pathways and to match reported in vivo levels of pathway intermediates and end-products 10, 11 . The detailed kMech inp uts, corresponding ODEs, kinetic rate constants, and initial conditions for solving the ODEs are presented in Supplementary Figure 1 online.
Allosteric Regulation of L-Threonine Deaminase
The allosteric regulatory mechanism of L-threonine deaminase was simulated with the MWC model employing physical parameters based on the literature and optimized as described in the Methods section. The data in Figure 2 show that Lthreonine deaminase produces α-ketobutyrate at a steady state level comparable to that observed in vivo 10, 11 , and the data in Figure 3 illustrate the response of this allosteric enzyme to changes in the levels of its effector ligands, L-isoleucine and L-valine. Since the K i for L-isoleucine (15 µM) is much less than the K a for L-valine (550 µM), an initial decrease in the fraction of active TDA as L-isoleucine accumulates is followed by an increase to a final steady level that accompanies the slower accumulation of L-valine ( Figs. 2 and 3) .
Regulation of the α -Acetohydroxyacid Synthase (AHAS) Isozymes
The two-substrate, two-product, AHAS isozymes I and III employ a Ping Pong Bi
Bi enzyme mechanism described in the Methods section (the AHAS II isozyme is
12 ) The L-valine inhibition of AHAS I and III is noncompetitive and, in the case of AHAS III, is incomplete since 15-20% of the activity attained at saturating substrate concentrations (V max ) remains in the presence of saturating L-valine concentrations 13 . The data in Figure 2 show that the production of α-acetolactate (αAL)
produced by AHAS isozymes I and III decreases as L-valine accumulates. These data also show that α-aceto-α-hyd roxybutyrate ( αAHB), primarily produced by AHAS isozyme III, decreases to a steady state level as its end-product inhibitor (L-valine)
accumulates, and as its substrate, α-ketobutyrate (αKB), decreases because L-isoleucine accumulates and inhibits L-threonine deaminase (Fig. 1 ). 13, 15 and by the activation of L-threonine deaminase that shuttles more substrate into the L-isoleucine pathway. Indeed, the simulation in Figure   4A shows that in the presence of extra-cellular L-valine, the intra-cellular L-isoleucine level in fact accumulates nearly nine-fold (Fig. 4A) . At the same time, the pathway precursor of L -isoleucine, α-ketobutyrate (αKB), increases about three-fold (Fig. 4B ).
Responses to Metabolic and Genetic Perturbations
This build-up of α-ketobutyrate (αKB) is caused by L-valine activation of L-threonine deaminase ( Fig. 4C ) which increases its production, and L-valine inhibition of the AHAS I and AHAS III isozymes, which reduces its consumption. It is now known that this α-ketobutyrate accumulation is toxic to cells because of its ability to inhibit the glucose PTS transport system 16, 17 . Thus, as reproduced by our simulations, L-valine growth inhibition of Escherichia coli K12 is not a consequence of L-isoleucine starvation.
The simulation results in Figure 4B show that the growth inhibiting effects of Lvaline induced α-ketobutyrate accumulation can be reversed by L -isoleucine by its ability to inhibit L-threonine deaminase activity. This simulation shows that, in the presence of 1 mM L-valine, the level of α-ketobutyrate increases around three-fold; and that in the presence of 500 µM L-isoleucine, α-ketobutyrate levels are reduced to the control level observed in the absence of L-valine. The simulation results in Figure 4C show that, concomitant with the rise in α-ketobutyrate observed in the presence of 1 mM L-valine, nearly 18% of the cellular L-threonine deaminase is converted to the active R state. However, concomitant with the decrease in α-ketobutyrate observed in the presence of 500 µM L -isoleucine, the cellular L -threonine deaminase in the active R state is reversed to the control level observed in the absence of L-valine. It is worth note that the results of these mathematical models are verified by experimental results accumulated from multiple laboratories over a three decade period 14, 16, 17 .
Metabolic Engineering L-Isoleucine Over-Production.
An obvious goal of modeling biological systems is to facilitate metabolic engineering for the commercial production of specialty chemicals such as amino acids. In the past, this has been largely accomplished by genetic manipulation and selection methods. For example, a common strategy to over-produce an amino acid has been to isolate a strain with a feedback resistant mutation in the gene for the first enzyme for the biosynthesis of that amino acid. Here we use our model to determine the effects of a feedback resistant L-threonine deaminase for the over-production of L -isoleucine. We can simulate a L-threonine deaminase resistant mutant strain by increasing the K i for Lisoleucine to a large number, (e.g. 100,000 µM). The simulation in Figure 5A shows that in the absence of L-isoleucine inhibition, the activator and substrate ligands drive nearly 100% of cellular feedback resistant L-threonine deaminase (TDA R ) to the active R state compared to the wild type enzyme that is only 6% present in the active R state. However, in spite of this increased L-threonine deaminase activity, the data in Figure 5B show that the amount of L-isoleucine produced in a feedback resistant E. coli K12 strain is only about 5 to 6 fold more than that produced by a wild type strain. On the other hand, the steady state level of α-ketobutyrate is increased about forty-fold (Fig. 5C ). This is because E. coli K12 does not have an active AHAS II isozyme that favors the condensation of pyruvate and α-ketobutyrate for L -isoleucine production; thus, α-ketobutyrate accumulates. These simulation results suggest that in order to over-produce L-isoleucine we must remove this bottle-neck. The results in Figure 5D show that restoring a wild type AHAS II isozyme and simulating an attenuator mutation that elevates the levels of all of the enzymes of the L-isoleucine and L -valine parallel pathways 11-fold 18 both avoids buildup of subsequent pathway intermediates ( In spite of the fact that E. coli genetic and metabolic regulation mechanisms have been studied for more than fifty years, not all the physical parameters required for the metabolic simulation of the branched chain amino acid biosynthetic pathways, or any pathways, are contained in the literature. However, to use the kMech reaction models we must know the kinetic rate and catalytic constants for each enzyme mechanism. Thus, it was necessary to develop methods to obtain robust estimates of these parameters from available kinetic data. In the Methods section we describe a Lambda (Λ) approximation method to estimate kinetic constants, k f and k r , from experimentally measured enzyme turnover numbers (k cat ) and K m values. We also describe an Omega (Ω) approximation method to estimate inhibition constants, k fi and k ri , from measured K m , K i , and estimated The first, or highest, level of control is exemplified by DNA-topology-dependent mechanisms that coordinate basal level expression of all of the genes of the cell (independent of operon-specific controls). This level is mediated by DNA architectural proteins and the actions of topoisomerases in response to nutritional and environmental growth conditions 21 . The second level of control is mediated by site-specific DNA binding proteins, which, in cooperation with operon-specific controls, regulate often overlapping groups of metabolically related operons in response to environmental or metabolic transitions or stress conditions. The third level of control is mediated by less abundant regulatory proteins that respond to operon-specific signals and bind in a sitespecific manner to one or a few DNA sites to regulate single operons. All of these regulatory levels participate in the regulation of the production of cellular proteins required for growth and intermediary metabolism. Each of these levels of control impacts metabolic regulation by influencing enzyme levels. Thus, a complete model of branched chain amino acid biosynthesis in E. coli must include these higher levels of gene regulation. To this end we are currently working on another software package, gMech, that will describe genetic regulatory mechanisms such as attenuation, activation and repression, and DNA topological mechanisms assembled from the fundamental association-dissociation reactions as in kMech. Ultimately, these kMech and gMech models will be integrated with built-in Cellerator signal transduction cascade and cell development models. These efforts will be appropriate for mathematically modeling the metabolic, genetic, and developmental systems of any organism.
METHODS
Lambda approximation method for enzyme rate constants:
In contrast to other models that simulate metabolic flux with Michaelis-Menton (2) In this case, the ratio of Consequently, the large quantity Q becomes a constant in this condition,
Therefore, we define Λ as a special case of Q above,
where Λ is a large time-invariant constant number, and the larger Λ is, the faster EnA reaches steady state equilibrium.
By rearrangement of (6), we can approximate k f as,
Now, by substitution of (8) into (4), we can approximate k r as
By substitution of equations (3) and (9) into the differential equa tion describing the state of EnA, we obtain,
If the value of Λ is large enough and close to Q ( 1 ≈ Λ Q ), the equation (10) ≈ 0,
and EnA reaches steady state equilibrium after a short time (equation (7)), which is the same as the Michaelis-Menton pseudo-steady state assumption 22 . To determine the value of Λ, we varied Λ from 10 to 1,000,000 in simulations with no significant changes in the steady levels of intermediates and end-products. Consequently, in simulations reported here, the value of Λ is always set to 100.
K m values are obtained from the literature, and k cat (mole/min/mole) values are calculated from Specific Activities (µmole/min/mg) and molecular weights of purified enzymes. However, because of uncertainties about the percentages of purified enzymes that are active, k cat values often require adjustments to fit experimental data.
The same Λ approximation methods, (7) and (8) are also used for multiple substrate and product enzymes that bind and release reactants in a Ping Pong fashion.
However, in the general case of two-substrate, two-product, enzymes that bind and release reactants in a Bi Bi fashion, k f and k r are approximated according to equations (10) and (11) . 
Omega approximation method for enzyme inhibition rate constants:
In addition to needing methods to approximate forward and reverse reaction rates of enzyme substrate binding reactions, k f , k r , we need to be able to estimate the forward and reverse rate constants for enzyme-inhibitor binding reactions, k fi , k ri . To accomplish this we define a value Ω that approximates the rate that an enzyme binds to its substrate relative to its inhibitor. Like the derivation of Λ, the derivation of Ω is based on the Michaelis-Menten pseudo-steady state assumption. The k fi is approximated by
, and k ri is approximated by
As shown in the detailed derivation provided as Supplementary Figure 2 online, value of Ω can be an arbitrary number if free enzyme, enzyme-inhibitor complex, and enzymesubstrate complex are in the steady state equilibrium. Consequently, in simulations reported here, the value of Ω is always set to 1.
A list of reported and optimized enzyme kinetic and physical parameters needed to solve the above equations can be found in Supplementary Table 1 online.
Approximation of Intracellular Enzyme Concentrations from Microarray analysis
With few exceptions, intracellular enzyme concentrations are not available.
However, with careful experimental documentation, these concentrations can be approximated from the yields and specific activities of purified enzymes. within two-fold to one-half adjustments of their inferred values.
Simulation of L-Threonine Deaminase Activity and Regulation
The concerted transition allosteric model of Monod, Wyman, and Changeux, the MWC model, is described by two equations 8 . The first equation describes the fraction of the enzyme in the or catalytically active state (R) as a function of substrate and effector concentrations.
The second equation describes the fractional saturation (Y f ) of the enzyme occupied by substrate as a function of substrate and effector concentrations. precursor, α-aceto-α-hydroxybutyrate (αAHB) (Fig. 1) . Each of these isozymes catalyzes their reactions with a Ping Pong Bi Bi enzyme mechanism 27 . It is an ordered Bi Bi mechanism because a pyruvate molecule must bind to the enzyme, react with a thiamine pyrophosphate cofactor to form an active acetaldehyde group (CH3CO), and release the first product, CO 2 , before the second substrate, pyruvate or α-ketobutyrate can bind to the enzyme. Next, the enzyme bound active acetoaldehyde group, must be transferred to the second substrate, pyruvate or α-ketobutyrate, to form the second product, α-acetolactate Since each of these pathway reactions share the glutamate substrate reaction, the Union operator is used to eliminate the duplicated first substrate reactions.
In this case, the channeling of carbon flow to end-products is controlled by the enzymepyridoxamine intermediate (TBNH2).
A similar approach was applied on the reverse reaction to eliminate the duplicated second substrate reaction
Extensions of Enzyme Reaction Models with Regulatory Circuits
The AHAS I and III isozymes are controlled by a noncompetitive inhibition mechanism 13 . This mechanism can be described by the following kMech input : Here, inh is the inhibitor name, kfi1, kri1, and kfi2, kri2 are inhibitor association and dissociation rate constants for the first and second substrate reactions, respectively, and NCI stands for non-competitive inhibition. residualRate is the fraction of maximal enzyme activity ( V max ) remaining at saturating inhibitor concentrations. The detailed reactions and equations that include these noncompetitive inhibition and residual activity parameters can be found as Supplementary Figure 4 online.
In the case of α-isopropylmalate synthase (IPMS), the binding of the first substrate acetyl-coA, is competitive ly inhibited by L-leucine; and the second substrate reaction with α-ketoisovalerate is non-competitively inhibited by L-leucine 29 Here CI stands for competitive inhibition. Other notations are as described above. The 
